sonar-pro
Allows the use of bracketing and matrixing study designs in pharmaceutical product stability testing.
{
  "id": "1e093a84-a413-4763-ae79-b4afb10033dd",
  "choices": [
    {
      "finish_reason": "stop",
      "index": 0,
      "logprobs": null,
      "message": {
        "content": "{\"answer\":\"YES\",\"note\":\"Singapore allows the use of bracketing and matrixing designs in pharmaceutical product stability testing because it aligns its regulatory framework with ASEAN guidelines, which are harmonized with ICH stability guidelines, including ICH Q1D covering bracketing and matrixing approaches[1][2]. While the ASEAN Guideline on Stability Study of Drug Product does not expressly mention 'bracketing' or 'matrixing' by name, ASEAN member states (including Singapore) generally accept these ICH-based scientific approaches when scientifically justified and appropriately documented, as ICH Q1D is internationally recognized for such study designs[2][3]. Sponsors are advised to provide proper scientific justification and may consider discussing the protocol with regulatory authorities to ensure acceptance, particularly for matrixing approaches, whose regulatory acceptance can vary depending on specific factors and product types[4].\"}",
        "refusal": null,
        "role": "assistant",
        "annotations": null,
        "audio": null,
        "function_call": null,
        "tool_calls": null
      },
      "delta": {
        "role": "assistant",
        "content": ""
      }
    }
  ],
  "created": 1755743977,
  "model": "sonar-pro",
  "object": "chat.completion",
  "service_tier": null,
  "system_fingerprint": null,
  "usage": {
    "completion_tokens": 177,
    "prompt_tokens": 21,
    "total_tokens": 198,
    "completion_tokens_details": null,
    "prompt_tokens_details": null,
    "search_context_size": "low",
    "cost": {
      "input_tokens_cost": 0.0,
      "output_tokens_cost": 0.003,
      "request_cost": 0.006,
      "total_cost": 0.009
    }
  },
  "citations": [
    "https://asean.org/wp-content/uploads/i-Final-ASEAN-Guideline-on-Stability-Study-Drug-Product-R2_uniformed-template.pdf",
    "https://www.ema.europa.eu/en/ich-q1d-bracketing-matrixing-designs-stability-testing-drug-substances-drug-products-scientific-guideline",
    "https://www.ich.org/page/quality-guidelines",
    "https://aapsopen.springeropen.com/articles/10.1186/s41120-023-00078-5",
    "http://academy.gmp-compliance.org/guidemgr/files/WHO_TRS_953_Annex2.pdf"
  ],
  "search_results": [
    {
      "title": "[PDF] ASEAN GUIDELINE ON STABILITY STUDY OF DRUG PRODUCT",
      "url": "https://asean.org/wp-content/uploads/i-Final-ASEAN-Guideline-on-Stability-Study-Drug-Product-R2_uniformed-template.pdf",
      "date": null,
      "last_updated": "2025-08-10"
    },
    {
      "title": "ICH Q1D Bracketing and matrixing designs for stability testing of ...",
      "url": "https://www.ema.europa.eu/en/ich-q1d-bracketing-matrixing-designs-stability-testing-drug-substances-drug-products-scientific-guideline",
      "date": null,
      "last_updated": "2025-08-21"
    },
    {
      "title": "Quality Guidelines - ICH",
      "url": "https://www.ich.org/page/quality-guidelines",
      "date": "2025-01-09",
      "last_updated": null
    },
    {
      "title": "Stability considerations for drug-device combination products-21 ...",
      "url": "https://aapsopen.springeropen.com/articles/10.1186/s41120-023-00078-5",
      "date": "2023-05-01",
      "last_updated": "2025-08-04"
    },
    {
      "title": "[PDF] Annex 2 Stability testing of active pharmaceutical ingredients and ...",
      "url": "http://academy.gmp-compliance.org/guidemgr/files/WHO_TRS_953_Annex2.pdf",
      "date": null,
      "last_updated": "2025-08-10"
    }
  ]
}